Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2025 Earnings Call Transcript November 6, 2025
Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.03.
Operator: Good morning, and welcome to Sangamo Therapeutics Third Quarter 2025 Conference Call. Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your speaker today, Louise Wilkie, Head of Investor Relations and Corporate...
